CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC. Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry)

Similar documents
CHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs

International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010

ANALYTICAL METHOD PROCEDURES

Chapter-4 EXPERIMENTAL WORK BY RP-HPLC

Asian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page:

Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

Analytical method development and validation of gabapentin in bulk and tablet dosage form by using UV spectroscopic method

CHAPTER 19 PARACETAMOL + IBUPROFEN

Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form

Impact factor: 3.958/ICV: 4.10 ISSN:

DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR DETERMINATION OF LOPINAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Revision Bulletin 27 Jan Feb 2017 Non-Botanical Dietary Supplements Compliance

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION

Revision Bulletin 29 Dec Jan 2018 Non-Botanical Dietary Supplements Compliance

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

Analytical Method Development and Validation of Lafutidine in Tablet dosage form by RP-HPLC

Research Article Available online at

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

Journal of Chemical and Pharmaceutical Research, 2017, 9(1): Research Article

Chapter 4: Verification of compendial methods

B. Anupama et al. IRJP 2 (1)

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

Analytical method development and validation of carvedilol in bulk and tablet dosage form by using uv spectroscopic method as per ich guidelines

Volume 6, Issue 2, January February 2011; Article-015

SPECTROPHOTOMETRIC METHODS FOR ESTIMATION OF MIZOLASTINE IN PHARMACEUTICAL DOSAGE FORMS

Method Development and Validation for the Estimation of Darunavir in Rat Plasma by RP-HPLC

NEW SPECTROPHOTOMETRIC METHODS FOR THE QUANTITATIVE ESTIMATION OF OXOLAMINE IN FORMULATION

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Estimation of zaleplon by a new RP-HPLC method

4.1 MATERIALS 4.2 EQUIPMENTS

AREA UNDER CURVE AND SECOND ORDER DERIVATIVE SPECTROSCOPY OF METAXALONE IN BULK DRUG AND TABLET FORMULATION

Research Article. Simultaneous spectrophotometric estimation of Paracetamol and Aceclofenac by second order derivative method in combined dosage form

DEVELOPMENT AND VALIDATION OF A SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF DRONEDARONE IN BULK DRUG AND PHARMACEUTICAL FORMULATION

Validated First Order Derivative Spectroscopic Method for the determination of Stavudine in Bulk and Pharmaceutical Dosage Forms

RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation

Stability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form

International Journal of Pharma and Bio Sciences V1(1)2010 UV- SPECTROPHOTOMETRIC DETERMINATION OF TENATOPRAZOLE FROM ITS BULK AND TABLETS

Development and validation of stability indicating reverse phase high performance liquid chromatography method for Timolol Maleate

International Journal of Pharma and Bio Sciences V1(1)2010. HPLC method for analysis of Lercanidipine Hydrochloride in Tablets

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

STABILITY INDICATING RP-HPLC METHOD FOR DETERMINATION OF EPROSARTAN IN PURE AND PHARMACEUTICAL FORMULATION

Research Article. Figure 1. Chemical structure of doxofylline. Indonesian J. Pharm. Vol. 24 No. 1 : ISSN-p :

Macrolides in Honey Using Agilent Bond Elut Plexa SPE, Poroshell 120, and LC/MS/MS

HPLC Method Development and Validation for the estimation of Esomeprazole in Bulk and Pharmaceutical Dosage Form

Praveen kumar.m 1 *, Sreeramulu.J 2. *Corres.author: Mobile no: India.

DEVELOPMENT AND VALIDATION OF NEW RP-HPLC METHOD FOR THE DETERMINATION OF AFLOQUALONE IN HUMAN PLASMA AND FORMULATION

ADVANTAME (TENTATIVE)

IDENTIFICATION OF STEROIDS IN COSMETIC PRODUCTS BY TLC AND HPLC 1 02/12/2005 ACM 007 A. THIN LAYER CHROMATOGRAPHY (TLC)

Available online Research Article

Ketorolac tromethamine (KT)[1] is

Available online at Scholars Research Library

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

Journal of Chemical and Pharmaceutical Research

DEVELOPMENT AND VALIDATION OF A STABILITY-INDICATING RP-HPLC METHOD FOR ASSAY OF IRBESARTAN IN PURE AND PHARMACEUTICAL DOSAGE FORM

Intrinsic Stability analysis and Assay Method for Determination of Fenofibrate in formulation by HPLC

Cu-Creatinine- Metol system

Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form

Journal of Drug Delivery and Therapeutics

Research Article Spectrophotometric Estimation of Didanosine in Bulk Drug and its Formulation

12 Nicarbazin Nicarbazin (4,4 -dinitro carbanilid (DNC) and 2-hydroxy-4,6-dimethyl pyrimidine (HDP))

UV Spectrophotometric Method Development and Validation of Ezetimibe and Simvastatin in Bulk and Pharmaceutical Dosage Form

Simultaneous Determination of Ramipril, Hydrochlorothizide and Telmisartan by Spectrophotometry

Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC

Draft Method proposal: determination of glucoheptonic acid (HGA) in fertilizers.

CYCLOSERINE Final text for addition to The International Pharmacopoeia. (November 2008) CYCLOSERINUM CYCLOSERINE

of nm throughout the experimental work.

SIMPLE AND SENSITIVE VALIDATED REVERSE PHASE HPLC-UV METHOD FOR THE DETERMINATION OF LYMECYCLINE IN PHARMACEUTICAL DOSAGE FORMS

Simultaneous Spectrophotometric Estimation of Aceclofenac and Paracetamol

Simultaneous UV Spectrophotometric Method for the Estimation of Cefuroxime Axetil and Probenecid from Solid Dosage Forms

High Performace Liquid Chromtographic Determination of Nicardipine Hydrochloride in Human Plasma

USP 36 Official Monographs / Metformin carding the first 3 ml of filtrate. Transfer 25 ml of the Analysis

A VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF PARACETAMOL AND DICLOFENAC POTASSIUM IN PHARMACEUTICAL FORMULATION

Spectrophotometric Determination of Ferrocyanide in Effluents

Pharmacophore 2011, Vol. 2 (4), ISSN Pharmacophore. (An International Research Journal)

Simultaneous estimation of ramipril and valsartan by RP-HPLC method in combined. dosage form

Department of Quality Assurance, Luqman College of Pharmacy, GULBARGA (K.S.) INDIA ABSTRACT

Annex 2 Formaldehyde

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

International Journal of Pharma and Bio Sciences

Impact factor: 3.958/ICV: 4.10 ISSN:

RP-HPLC Estimation of Trospium Chloride in Tablet Dosage Forms

Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form

Dissolution Test 5 was validated using a Zodiac C18 brand of L1 column. The typical retention time for atorvastatin is about min.

ESTIMATION OF LORNOXICAM IN TABLET DOSAGE FORM BY UV SPECTROPHOTOMETRIC METHOD

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

ISSN: ; CODEN ECJHAO E-Journal of Chemistry , 9(1), 35-42

Development and validation of septrophotometricmethods for the estimation of rasagiline in tablet doage form

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: , ISSN(Online): Vol.9, No.7, pp , 2016

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Egualen Sodium Granules

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Analytical Method Development and Validation of Secnidazole Tablets by RP-HPLC

Development Of New Analytical Method For The Determination Of Bromfenac In Bulk And Marketed Formulation And Its Validation

DEVELOPMENT AND VALIDATION OF HPLC METHOD OF DISSOLUTION TEST FOR METOPROLOL SUCCINATE AND CILNIDIPINE

Journal of Chemical and Pharmaceutical Research, 2014, 6(7): Research Article

Rapid Screening and Confirmation of Melamine Residues in Milk and Its Products by Liquid Chromatography Tandem Mass Spectrometry

Ondansetron Hydrochloride Tablets

Transcription:

CHAPTER V ANALYTICAL METHODS ESTIMATION OF DICLOFENAC A UV spectrophotometric method based on the measurement of absorbance at 276nm in phosphate buffer of p H 7.4 was used in the present study of the estimation of diclofenac sodium. Materials: Diclofenac (gift sample from M/s Micro Labs Ltd., Pondicherry) Methanol (Qualigens) Potassium dihydrogen phosphate (Qualigens) Sodium hydroxide (Qualigens) Reagents: Phosphate buffer of p H 7.4 Phosphate buffer of p H 7.4 was made by dissolving 6.8 g of potassium dihydrogen phosphate and 1.56 g of sodium hydroxide in 1000 ml with distilled water. The p H was adjusted to 7.4. Standard solution: 10 mg of diclofenac sodium was dissolved in methanol in 25 ml volumetric flask and the solution was made up to volume with methanol. Procedure: The standard solution of diclofenac was subsequently diluted with phosphate buffer of p H 7.4 to obtain series of dilutions containing 2,4,6,8 and 10 μg of diclofenac sodium per ml of solution. The absorbance of the above dilutions was measured in Elico BL 198 double beam UV Spectrophotometer at 276 nm using phosphate buffer of p H 7.4 as blank. The concentrations of diclofenac and corresponding absorbances are given in 73

Table 5.1. The absorbance values were plotted against concentration of diclofenac as shown in Figure 5.1 and this calibration curve was used for the estimation of diclofenac in test samples in all in vitro studies. Validation of method The method was validated for linearity, accuracy, precision and interference by other materials used in the present study. Accuracy and precision (Reproducibility) of the method was studied by analyzing six individually weighed samples of diclofenac. Interference by the other materials was evaluated by preparing a physical mixture of diclofenac and cross linked starch urea in 1:1 ratio and analyzing the samples of mixtures for diclofenac content by the proposed method. 74

Table 5.1 Calibration Curve for the Estimation of Diclofenac by UV Spectrophotometric method (Using P H 7.4 Phosphate Buffer) Concentration Absorbance (μg / ml) 0 2 4 6 8 10 _ x 0 0.075 0.145 0.215 0.284 0.357 RSD 0 0.32 0.28 0.44 0.26 0.16 75

0.40 0.35 0.30 Absorbance 0.25 0.20 0.15 0.10 0.05 r ² = 0.9998 y = 0.0354 x + 0.0020 0.00 0 2 4 6 8 10 12 Concentration ( g/ml) Fig 5.1 Calibration curve for the estimation of Diclofenac 76

Discussion: The method obeyed Beer s law in the concentration range of 0 10 μg/ml. Low RSD values (Table 5.1.) ensured reproducibility of the method. The mean error (accuracy) and relative standard deviation (precision) were found to be 0.8 % and 1.6%, respectively. The cross linked starch urea did not interfere in the method of estimation. Recovery of the diclofenac from the physical mixture of drug and polymer was found to be 99.5%. Thus the method was found to be suitable for the estimation of diclofenac contents in various products and in vitro dissolution studies in the present investigation. 77

ESTIMATION OF ACECLOFENAC A spectrophotometric method based on the measurement of absorbance at 275 nm in phosphate buffer of ph 6.8 was used in the present study for the estimation of aceclofenac. Materials Aceclofenac (gift sample from M/s Suyaash Labs, Chennai) Methanol (Qualigens) Potassium dihydrogen phosphate (Qualigens) Sodium hydroxide (Qualigens) Reagents Phosphate buffer of ph 6.8: Phosphate buffer of ph 6.8 was made by mixing 250 ml of 0.2 M potassium hydrogen phosphate with 112 ml of 0.2 N sodium hydroxide and making upto 1000 ml with freshly boiled and cooled distilled water. The ph was adjusted to 6.8 Standard Solution 25 mg of aceclofenac was dissolved in methanol in a 25 ml of volumetric flask and the solution was made upto volume with methanol. Procedure The standard solution of aceclofenac was subsequently diluted with phosphate buffer of ph 6.8 to obtain a series of dilutions containing 2, 4, 6, 8 and 10 g of aceclofenac in 1 ml solution. The absorbance of these solutions was measured in Elico-SL 159, UV-Vis Spectrophotometer at 275 nm using phosphate buffer of ph 6.8 as blank. The concentration of aceclofenac and the corresponding absorbances are given in Table 78

5.2. The absorbances were plotted against concentration of aceclofenac as shown in Fig. 5.2. Validation of method The method was validated for linearity, accuracy, precision and interference by other materials used in the present study. Accuracy and precision (Reproducibility) of the method was studied by analyzing six individually weighed samples of aceclofenac. Interference by the other materials was evaluated by preparing a physical mixture of aceclofenac and cross linked starch urea in 1:1 ratio and analyzing the samples of mixtures for aceclofenac content by the proposed method. Table 5.2 Calibration Curve for the Estimation of Aceclofenac by UV Spectrophotometric Method Aceclofenac Absorbance Concentration ( g/ml) x RSD (%) 0 0 0 2 0.063 0.315 4 0.121 0.280 6 0.185 0.163 8 0.243 0.155 10 0.296 0.450 79

Absorbance 0.3 0.25 y = 0.029x + 0.002 R² = 0.999 0.2 0.15 0.1 0.05 0 0 2 4 6 8 10 Concentration (µg/ml) Fig.5.2. Calibration Curve for the Estimation of Aceclofenac by UV Spectrophotometric Method Discussion: The method obeyed Beer s law in the concentration range of 0 10 μg/ml. Low RSD values (Table 5.2.) ensured reproducibility of the method. The mean error (accuracy) and relative standard deviation (precision) were found to be 0.6 % and 1.2%, respectively. The cross linked starch urea did not interfere in the method of estimation. Recovery of the aceclofenac from the physical mixture of drug and polymer was found to be 99.2%. Thus the method was found to be suitable for the estimation of aceclofenac contents in various products and in vitro dissolution studies in the present investigation. 80

HPLC METHOD FOR THE ESTIMATION OF DICLOFENAC IN PLASMA Plasma concentrations of diclofenac were determined by an HPLC method developed by Chowdary, K. P. R. and Murali Krishna M. N 1. as follows Instrumentation: The following system is used. The HPLC system (make: M/s Shimadzu Corporation, Japan.) consisted of UV- Visible detector (Shimadzu, Model: SPD 10 AVP), C-18 column (Phenomenex, DESC: Gemini 5 µ C18 110 A, Size: 250 x 4.6 mm, S/No: 288063 23), 2 pumps (Model: LC 10 ATVP) and a microsyringe of capacity 25 µl (model: Microliter # 702, Mfd: M/s Hamilton). Mobile Phase: The mobile phase is a mixture of acetonitrile: 0.01M potassium dihydrogen phosphate (ph 6.3) (50:50). The mobile phase was filtered through 0.45 µ membrane filter before use and was run at a flow rate of 1 ml/min. Detection: The column effluent was monitored at 276 nm. Estimation of Diclofenac in plasma: For the estimation of diclofenac in plasma samples, a calibration curve was constructed initially by analyzing plasma samples containing different amounts of diclofenac as follows. To a Series of tubes containing 0.5 ml of plasma samples in each, 0.1 ml drug solution containing 1, 2, 4 and 6 µg of diclofenac were added and mixed. To each tube 1 ml of acetonitrile was added, mixed thoroughly and centrifuged at 5000 rpm for 20 min. The organic layer (0.5 ml) was taken into a dry tube and the acetonitrile was evaporated. To the dried residue 0.5 ml of mobile phase [a mixture of acetonitrile: 0.01M potassium 81

dihydrogen phosphate (ph 6.3) (50:50)] was added and mixed for reconstitution. Subsequently 20 µl were injected into the column for HPLC analysis. The plasma concentrations of diclofenac and the corresponding peak areas are given in Table 5.3. This calibration curve (Fig. 5.3) was used for the estimation of diclofenac in the plasma samples collected in the pharmacokinetic evaluation. Table 5.3 Calibration Curve for the Estimation of Diclofenac in Plasma Samples by HPLC Method Diclofenac Concentration (µg/0.5 ml of plasma) Mean Peak Area (m V. s) RSD (%) 1.0 2.0 4.0 6.0 385.6 786.5 1535.2 2309.5 1.42 1.85 2.0 1.94 82

2500 2000 Area (mv.s) 1500 1000 500 r ² = 0.9999 y = 384.1689 x + 4.5206 0 0 1 2 3 4 5 6 7 plasma concentration ( g/ml) Fig. 5.3: Calibration curve for the Estimation of Diclofenac in Plasma Samples by HPLC Method REFFERENCES 1. Chowdary, K.P.R. and Murali Krishna M.N., Asian Journal of Chemistry (in press). 83